Our Board of Directors offers a diverse and complementary skill set, well positioned to drive accountability and outcomes.
In December 2020, we expanded the Board to bring additional capabilities, experience, and expertise to deliver consistent, sustainable increases in value while integrating an investor perspective. The added and expanded committees are focused on enhancing strategy and execution.
Lawrence E. Kurzius is the Chairman of the Elanco Board of Directors.
Jeffrey N. Simmons serves as president and CEO of Elanco Animal Health.
Kapila Kapur Anand has served as a member since September 2018.
John P. Bilbrey has served as a member since March 2019.
William F. Doyle has served as a member since December 2020.
Art A. Garcia has served as a member since May 2019.
Michael J. Harrington has served as a member since September 2018.
Paul Herendeen has served as a member since December 2020.
R. David Hoover has served as a member since September 2018.
Deborah T. Kochevar has served as a member since March 2019.
Stacey Ma, PhD, has served as a member of the Elanco Board of Directors since November 2024.
Kirk McDonald has served as a member since March 2019.
Denise Scots-Knight has served as a member since March 2019.
Kathy Turner has served as a member since March 2024.
Craig Wallace has served as a member since March 2024.
Our Directors have background in livestock production, veterinary medicine and innovation, integration, finance, accounting, operational improvement, digital transformation, the food industry, and consumer insights.
Our Board has added eight new independent directors since 2019, including the addition of an investor representative in 2020. The Board values diversity in experience, viewpoints, gender and ethnicity.
Our Board of Directors is responsible for the general oversight of Elanco business and performance, including providing guidance for corporate strategy, legal compliance, ethical conduct, and evaluating the management of business. Specific responsibilities are also delegated to individual committees of the board.
Board Of Directors
Audit Committee
Compensation & Human Capital Committee
Corporate Governance Committee
Finance, Strategy and Oversight Committee
Innovation, Science and Technology Committee
Our Board of Directors is responsible for the general oversight of Elanco business and performance, including providing guidance for corporate strategy, legal compliance, ethical conduct, and evaluating the management of business. Specific responsibilities are also delegated to individual committees of the board.
Lawrence E. Kurzius
Chair
Jeffrey N. Simmons
Member
Kapila K. Anand
Member
John P. Bilbrey
Member
William F. Doyle
Member
Scott D. Ferguson
Member
Art A. Garcia
Member
Michael J. Harrington
Member
Paul Herendeen
Member
R. David Hoover
Member
Deborah T. Kochevar
Member
Stacey Ma
Member
Kirk P. McDonald
Member
Denise Scots-Knight
Member
Kathy Turner
Member
Craig Wallace
Member
For further information, please see our latest Proxy Statement.
Read more stories from our spotlight employees and their experience at Elanco
Learn why we're a leading provider of innovative solutions that protect and enhance animal health.
Read About ElancoElanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2024 Elanco or its affiliates.
